These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A case of probable bemiparin-induced HIT type II managed with low-dose fondaparinux. Koufakis T; Tsapakidis K; Margaritis A; Gabranis I J Postgrad Med; 2015; 61(2):109. PubMed ID: 25766343 [No Abstract] [Full Text] [Related]
25. Severe thrombocytopenia after heparin therapy in a patient with unstable angina and recent stent implantation. Sideris SK; Bonios MJ; Eftihiadis EE; Melexopoulou CA; Mousiama TA; Diplaris KT; Kogias JS Hellenic J Cardiol; 2005; 46(3):242-6. PubMed ID: 15981562 [TBL] [Abstract][Full Text] [Related]
26. Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin. Warkentin TE Thromb Haemost; 2008 Jan; 99(1):2-3. PubMed ID: 18217128 [No Abstract] [Full Text] [Related]
27. Can heparin-induced thrombocytopenia be associated with fondaparinux use? A rebuttal. Elalamy I; Tribout B J Thromb Haemost; 2008 Jul; 6(7):1242-3; author reply 1243-6. PubMed ID: 19330935 [No Abstract] [Full Text] [Related]
28. Pulmonary embolectomy in heparin-induced thrombocytopenia and thrombosis? Safety of heparin use. Sachithanandan A Interact Cardiovasc Thorac Surg; 2010 Nov; 11(5):681. PubMed ID: 20962169 [No Abstract] [Full Text] [Related]
29. Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia. Efird LE; Kockler DR Ann Pharmacother; 2006; 40(7-8):1383-7. PubMed ID: 16788093 [TBL] [Abstract][Full Text] [Related]
30. Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues. Blackmer AB; Oertel MD; Valgus JM Ann Pharmacother; 2009 Oct; 43(10):1636-46. PubMed ID: 19737996 [TBL] [Abstract][Full Text] [Related]
31. Heparin-induced thrombocytopenia in a hemodialysis patient treated with fondaparinux: nephrologists between two fires. Solak Y; Demircioglu S; Polat I; Biyik Z; Gaipov A; Acar K; Turk S Hemodial Int; 2013 Apr; 17(2):320-3. PubMed ID: 22631215 [TBL] [Abstract][Full Text] [Related]
32. Choice of drugs for heparin-induced thrombocytopenia. Med Lett Drugs Ther; 2012 May; 54(1391):43-4. PubMed ID: 22643441 [No Abstract] [Full Text] [Related]
33. Voting with your fondaparinux. Warkentin TE Thromb Res; 2014 Jul; 134(1):3-4. PubMed ID: 24787988 [No Abstract] [Full Text] [Related]
34. Heparin-induced thrombocytopenia: a review of current pharmacologic treatment. Talati R; Colemen CI; White CM Conn Med; 2008 May; 72(5):275-9. PubMed ID: 18593063 [No Abstract] [Full Text] [Related]
35. Prolonged use of fondaparinux for perioperative bridging: a case report of a patient with mechanical heart valve and heparin-induced thrombocytopenia. Wei M; Wang CT; Li DM; Song XJ J Clin Pharm Ther; 2015 Dec; 40(6):702-5. PubMed ID: 26573868 [TBL] [Abstract][Full Text] [Related]
36. Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study. Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Kropff S; Müller MM; Lindhoff-Last E Thromb Res; 2014 Jul; 134(1):29-35. PubMed ID: 24703295 [TBL] [Abstract][Full Text] [Related]
37. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia. Lobo B; Finch C; Howard A; Minhas S Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156 [TBL] [Abstract][Full Text] [Related]
39. The paradox of heparin induced thrombocytopenia-thrombosis, the role of fondaparinux and the need for new therapeutic strategies. Kounis NG; Koniari I; Soufras GD; Tsigkas G; Plotas P; Davlouros P; Hahalis G Int Angiol; 2020 Aug; 39(4):350-351. PubMed ID: 32214073 [No Abstract] [Full Text] [Related]